Jsb Market Research: Immunotherapy Development Strategies - an Evolving Market with Significant Potential but with Challenging Hurdles to Overcome

Immunotherapy Development Strategies - An Evolving Market with Significant Potential but with Challenging Hurdles to Overcome

Released On 16th February 2015

Although immunotherapy was first recognized over 100 years ago, it has only become an important therapeutic tool in recent decades. The immune system can be harnessed in one of several ways to tackle various diseases such as cancer, infection, auto-immune disease and inflammatory diseases.

The complexity of the immune system has led to some intrinsic obstacles with clinical research, particularly in relation to targeting the right genes, identifying the appropriate patient population and accessing internal tissues for testing.

Market access presents a significant hurdle for immunotherapeutics, as many are high cost and do not deliver the measurements required for traditional cost-effectiveness assessments.

Oncology has been a primary area of focus for immunotherapeutics, largely due to the potential offered by this market but also due to the critical role the immune system plays in the proliferation of cancer throughout the body.

Auto-immune and inflammatory diseases are also attractive targets for immunotherapy, with several different approaches being investigated.

The report, Immunotherapy Development Strategies - An Evolving Market with Significant Potential but with Challenging Hurdles to Overcome was written to support executives within both the commercial and R&D sides of the biopharmaceutical industry. It provides key insights through the analysis of issues, trends, and the future outlook of immunological therapies to support executive decision making for both biotech and pharmaceuticals companies alike.

Scope

 Immunotherapy Overview

 Immunotherapeutic Development and Launch Strategies

 Trends in the Development of Immunotherapeutics

 The Immunotherapeutics Market

 Key Companies Involved in Immunotherapeutics

 Case Studies

 Future outlook

Key Reasons to Purchase...